Free Trial
NASDAQ:ZIVO

ZIVO Bioscience (ZIVO) Stock Price, News & Analysis

ZIVO Bioscience logo
$13.00 +1.01 (+8.42%)
As of 02:59 PM Eastern

About ZIVO Bioscience Stock (NASDAQ:ZIVO)

Key Stats

Today's Range
$13.00
$13.00
50-Day Range
$11.99
$18.80
52-Week Range
$5.80
$22.15
Volume
338 shs
Average Volume
988 shs
Market Capitalization
$49.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZIVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

ZIVO Stock News Headlines

5 Stocks Poised to Soar Under Trump's Presidency
With the next presidential cycle heating up and Trump leading the charge, major market shifts are already taking shape. For investors who position early, the opportunities could be significant. That’s why we’ve just released a brand-new report: 📈 “5 Best Stocks to Buy Under Trump’s Presidency.”
See More Headlines

ZIVO Stock Analysis - Frequently Asked Questions

ZIVO Bioscience's stock was trading at $21.50 at the start of the year. Since then, ZIVO shares have decreased by 39.5% and is now trading at $13.00.

ZIVO Bioscience, Inc. (NASDAQ:ZIVO) released its quarterly earnings data on Monday, May, 11th. The biotechnology company reported ($0.06) earnings per share for the quarter. The biotechnology company had revenue of $0.02 million for the quarter.

ZIVO Bioscience shares reverse split on the morning of Friday, October 27th 2023.The 1-6 reverse split was announced on Friday, October 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ZIVO Bioscience investors own include Canopy Growth (CGC), Meta Platforms (META), OPKO Health (OPK), Johnson & Johnson (JNJ), ACADIA Pharmaceuticals (ACAD), ARAVIVE (ARAV) and Alibaba Group (BABA).

Company Calendar

Last Earnings
5/11/2020
Today
7/07/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZIVO
Previous Symbol
OTCMKTS:HEPI
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.78 million
Pretax Margin
-17,113.75%

Debt

Sales & Book Value

Annual Sales
$15.85 thousand
Price / Cash Flow
N/A
Book Value
($0.81) per share
Price / Book
-14.80

Miscellaneous

Free Float
2,911,000
Market Cap
$45.72 million
Optionable
Not Optionable
Beta
0.02

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:ZIVO) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners